Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2010 2
2011 1
2012 2
2013 2
2014 3
2015 1
2016 3
2017 1
2019 1
2020 3
2021 1
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Tissue, 2Fchemistry, 5BMAJR
Page 1
Thiazolopyrimidine Scaffold as a Promising Nucleus for Developing Anticancer Drugs: A Review Conducted in Last Decade.
Islam MR, Fahmy H. Islam MR, et al. Anticancer Agents Med Chem. 2022;22(17):2942-2955. doi: 10.2174/1871520622666220411110528. Anticancer Agents Med Chem. 2022. PMID: 35410622 Review.
The thiazolopyrimidine nucleus is a bioisosteric analog of purine and an important class of N-containing heterocycles. Thiazolopyrimidine scaffolds are considered a promising class of bioactive compounds that encompass diverse biological activities, such as antibacterial, …
The thiazolopyrimidine nucleus is a bioisosteric analog of purine and an important class of N-containing heterocycles. Thiazolopyrimidine …
Electrohydrodynamic printing of submicron-microscale hybrid scaffolds with improved cellular adhesion and proliferation behaviors.
Zhang B, Li S, He J, Lei Q, Wu C, Song A, Zhang C. Zhang B, et al. Nanotechnology. 2022 Dec 23;34(10). doi: 10.1088/1361-6528/aca97f. Nanotechnology. 2022. PMID: 36562511
The microscale scaffolds were utilized as a control group. Rat myocardial cells (H9C2 cells) were cultured on the two kinds of scaffolds for the culturing period of 1, 3 and 5 d. Biological results indicated that H9C2 cells showed enhanced adhesion and proliferation …
The microscale scaffolds were utilized as a control group. Rat myocardial cells (H9C2 cells) were cultured on the two kinds of sca …
Synthesis and Anticancer Evaluation of New Thiazole and Thiadiazole Derivatives Bearing Acetanilide Moiety.
El-Rayyes A, Soliman AM, Saeed A. El-Rayyes A, et al. Russ J Gen Chem. 2022;92(10):2132-2144. doi: 10.1134/S1070363222100267. Epub 2022 Nov 8. Russ J Gen Chem. 2022. PMID: 36408422 Free PMC article.
The Knoevenagel reaction of 3b with various aromatic aldehydes afforded 5-arylidene-2-phenyliminothiazolidin-4-one derivatives 5a-5e. Intramolecular cyclization of thiourea scaffold 2 with chloroacetone and/or phenacyl chloride gave the conforming thiazole derivatives 6a a …
The Knoevenagel reaction of 3b with various aromatic aldehydes afforded 5-arylidene-2-phenyliminothiazolidin-4-one derivatives 5a-5e. Intram …
Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds.
Sinha S, Kumaran AP, Mishra D, Paira P. Sinha S, et al. Bioorg Med Chem Lett. 2016 Nov 15;26(22):5557-5561. doi: 10.1016/j.bmcl.2016.09.078. Epub 2016 Oct 1. Bioorg Med Chem Lett. 2016. PMID: 27769619
A fluorogenic version of 1,3-dipolar cycloaddition between azides and alkynes (DBCO) has been introduced to develop the triazolylcoumarin based fluorescent scaffolds. These scaffolds were screened for their anticancer activity against breast cancer (MCF7) and human …
A fluorogenic version of 1,3-dipolar cycloaddition between azides and alkynes (DBCO) has been introduced to develop the triazolylcoumarin ba …
Novel N,N'-Disubstituted Acylselenoureas as Potential Antioxidant and Cytotoxic Agents.
Ruberte AC, Ramos-Inza S, Aydillo C, Talavera I, Encío I, Plano D, Sanmartín C. Ruberte AC, et al. Antioxidants (Basel). 2020 Jan 8;9(1):55. doi: 10.3390/antiox9010055. Antioxidants (Basel). 2020. PMID: 31936213 Free PMC article.
The breast cancer cells turned out to be much more sensitive than the lung. Two compounds (5d and 10a) stood out with IC(50) values between 4.2 muM and 8.0 muM towards MCF-7 and T47D cells, with selectivity indexes greater than 22.9. In addition, compound 10b exhibi …
The breast cancer cells turned out to be much more sensitive than the lung. Two compounds (5d and 10a) stood out with IC(50) values b …
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB): 2-year results from the GABI-R-registry.
Pahmeier K, Neusser S, Hamm C, Kastner J, Wöhrle J, Zahn R, Achenbach S, Mehilli J, Gori T, Naber C, Nef H, Neumann T, Richardt G, Schmermund A, Claas C, Riemer T, Biermann-Stallwitz J; GABI-R Study Group. Pahmeier K, et al. BMC Cardiovasc Disord. 2022 Aug 20;22(1):379. doi: 10.1186/s12872-022-02815-2. BMC Cardiovasc Disord. 2022. PMID: 35987601 Free PMC article.
BACKGROUND: Numerous studies have reported clinical endpoints following coronary revascularization using bioresorbable vascular scaffolds (BVS), while information about the impact on health-related quality of life is sparse. ...Reasons for revascularization were: ACS (n = …
BACKGROUND: Numerous studies have reported clinical endpoints following coronary revascularization using bioresorbable vascular scaffolds …
New Fluoroquinolone-1,2,4-triazoles as Potent Antibacterial Agents: Design, Synthesis, Docking Studies and in Silico ADME Profiles.
Rao Gollapalli V, Babu Bollikolla H, Rao Allaka T, Ranga Rao Vaddi P, Basireddy S, Ganivada M, Reddy Pindi S. Rao Gollapalli V, et al. Chem Biodivers. 2023 Apr;20(4):e202201259. doi: 10.1002/cbdv.202201259. Epub 2023 Apr 19. Chem Biodivers. 2023. PMID: 36924103
The newly synthesized 1,2,4-triazole derivatives were tested in vitro for their ability to inhibit the growth of seven different microbes including S. epidermidis, S. pneumoniae, S. aureus, B. subtilis, K. pneumoniae, E. coli, and P. aeruginosa. Five FQ derivatives 5d, 5e, …
The newly synthesized 1,2,4-triazole derivatives were tested in vitro for their ability to inhibit the growth of seven different microbes in …
Green synthesis and biological evaluation of 6-substituted-2-(2-hydroxy/methoxy phenyl)benzothiazole derivatives as potential antioxidant, antibacterial and antitumor agents.
Racané L, Ptiček L, Fajdetić G, Tralić-Kulenović V, Klobučar M, Kraljević Pavelić S, Perić M, Paljetak HČ, Verbanac D, Starčević K. Racané L, et al. Bioorg Chem. 2020 Jan;95:103537. doi: 10.1016/j.bioorg.2019.103537. Epub 2019 Dec 23. Bioorg Chem. 2020. PMID: 31884142
Newly synthesized compounds were designed to study the influence of the hydroxy and methoxy groups on the 2-arylbenzothiazole scaffold, as well as the influence of the type of substituents placed on the C-6 position of benzothiazole moiety on biological activity, including …
Newly synthesized compounds were designed to study the influence of the hydroxy and methoxy groups on the 2-arylbenzothiazole scaffold …
A Rational Approach To Antitubercular Drug Design: Molecular Docking, Prediction of ADME Properties and Evaluation of Antitubercular Activity of Novel Isonicotinamide Scaffold.
Das P, Gumma SR, Nayak A, Menghani S, Mandhadi JR, Prabhu PP. Das P, et al. Recent Adv Antiinfect Drug Discov. 2024;19(2):148-158. doi: 10.2174/2772434418666230710142852. Recent Adv Antiinfect Drug Discov. 2024. PMID: 37723955
RESULTS: The analysis was based on the binding energy and minimum inhibitory concentration (MIC). The highest and lowest binding energy is -4.22 Kcal/mol (f) and -8.45 Kcal/mol (d), and the MIC for compound d was found to be 644.22 nM. Among all the ligands, compoun …
RESULTS: The analysis was based on the binding energy and minimum inhibitory concentration (MIC). The highest and lowest binding energy is - …
Complex Osteochondral Lesions of the Talus Treated With a Novel Bi-Phasic Aragonite-based Implant.
Drobnič M, Kolar M, Verdonk P, Vannini F, Robinson D, Altschuler N, Shabshin N, Kon E. Drobnič M, et al. J Foot Ankle Surg. 2021 Mar-Apr;60(2):391-395. doi: 10.1053/j.jfas.2020.06.028. Epub 2020 Sep 5. J Foot Ankle Surg. 2021. PMID: 33246791 Free article.
To present initial results of a novel, bi-phasic, porous, biodegrade, and cell-free aragonite-based scaffold for treating complex osteochondral lesions of the talus (OLT). ...Treatment outcome was followed clinically (Foot and Ankle Outcome Score, EQ-5D 3L, Tegner a …
To present initial results of a novel, bi-phasic, porous, biodegrade, and cell-free aragonite-based scaffold for treating complex ost …
25 results